Objective: Patients with end-stage renal disease have multiple comorbidities and are at increased risk for postoperative complications and resource utilization. Our goal was to determine the rate and causes of 30-day and 90-day hospital readmissions after the creation of outpatient hemodialysis access.
Results:
We identified 537 patients (60% male). Average age was 59 years. Access type included radiocephalic (4.5%), brachiocephalic (50.7%), brachiobasilic (22.5%), and prosthetic (20%) arteriovenous fistulas. The 90-day mortality rate was 0.7%. Postoperative hospital readmission rates were 25.5% at 30 days and 47.7% at 90 days. Reasons for admission were access related in 10.9% and dialysis catheter related in 6.9%. Other reasons for admission included shortness of breath/ volume overload (15.8%), gastrointestinal (11.9%), cardiac/chest pain (10.9%), unrelated infectious causes (11.9%), failure to thrive (5%), altered mental status (4%), electrolyte abnormalities (3%), and musculoskeletal (2.5%). Preoperative predictors of all cause 30-day readmission included dementia (odds ratio [OR], 5.76; 95% confidence interval [CI], 1.34-24.8; P ¼ .018), hypertension (OR, 3.92; 95% CI, 1.07-14.4; P ¼ .039), chronic obstructive pulmonary disease (OR, 2.19; 95% CI, 1.01-4.76; P ¼ .046), and current smoking (OR, 2.14; 95% CI, 1.32-3.47; P ¼ .002). Predictors of all cause 90-day readmission were hepatic insufficiency (OR, 6.08; 95% CI, 1.2-30.8; P ¼ .029), hypertension (OR, 3.43; 95% CI, 1.36-8.65; P ¼ .009), black race (OR, 2.47; 95% CI, 1.48-4.14; P ¼ .001), Hispanic ethnicity (OR, 2.04; 95% CI, 1.01-4.11; P ¼ .046), and obesity (OR, 1.5; 95% CI, 1.02-2.19; P ¼ .039). Predictors of 90-day access-related readmission included chronic obstructive pulmonary disease (OR, 5.27; 95% CI, 1.38-20.0; P ¼ .015), previous stroke (OR, 3.76; 95% CI, 1.5-9.4; P ¼ .005), being on dialysis at time of the operation (OR, 2.8; 95% CI, 1.17-6.84; P ¼ .022), and prosthetic graft placement (OR, 2.86; 95% CI, 1.07-7.6; P ¼ .036). An additional 9.7% had at least one emergency department presentation #90 days but were not admitted.
Conclusions:
Patients undergoing placement of hemodialysis access are at high risk for readmission mostly from causes unrelated to their operation. This has an effect for global care for these patients as well as care of these patients in accountable care organizations. (J Vasc Surg 2017; 65:1376-82.) Hospital readmission rates are used as an indicator for quality of care in many hospitals. 1 However, the proportion of readmissions that may be preventable is unclear. 1,2 The
Center for Medicare and Medicaid Services (CMS) showed that readmissions in 2011 cost w$24 billion. 3 Readmission rates in Medicare beneficiaries have been reported as 19.6% at 30 days and 34% at 90 days. 4 Vascular surgery readmission rates are among the highest. [5] [6] [7] [8] [9] [10] [11] These readmissions are costly, and therefore, prospectively identifying patients at high risk for readmission after vascular surgery operations is important. 9, 12 Upper extremity vascular access operations are common vascular procedures that have a relatively low perioperative morbidity and mortality and are often ambulatory procedures. 13 Despite this, dialysis-access patients are at risk for readmission because they all have end-stage renal disease, which has been independently associated with high readmission rates. 9,10 Analysis of readmission rates after outpatient upper extremity hemodialysis access creation has not been characterized. Readmission rates in these patients could affect hospital reimbursement and overall provide a financial strain, especially for bundled care such as in accountable care organizations. Our goal was to assess rates of readmission after outpatient upper extremity vascular hemodialysis access procedures to provide baseline data for quality improvement. We queried Boston Medical Center's patient database for all patients who underwent outpatient upper extremity hemodialysis creation from 2008 to 2015 to examine the details of our 30-day and 90-day readmission rate.
METHODS
A retrospective record review was conducted of all patients who underwent outpatient upper extremity hemodialysis access procedures at Boston Medical Center between 2008 and 2015. The study excluded in-patients undergoing hemodialysis access creation. The Boston University School of Medicine Institutional Review Board approved this study, and patient consent was waived.
Procedural details, demographics, and patient comorbidities were recorded. Access fistulas were categorized into radiocephalic, brachiocephalic, brachiobasilic, prosthetic, and other. All brachiobasilic fistulas were performed as one-stage transpositions. Patient characteristics considered in the analysis included age, gender, race, and insurance. Patient comorbidities included ambulatory status, obesity (defined as body mass index $30 kg/m 2 ), current smoking status, diabetes, hypertension, coronary artery disease (CAD), congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), peripheral vascular disease (PVD), liver failure, dialysis status at the time of the operation, dementia, prior cerebral vascular accident, and last preoperative potassium value >5 mmol/L. The main outcome measured in the study was 30-day and 90-day patient readmission, which was defined as any inpatient status admission after the outpatient procedure. Readmissions were further subclassified by the cause for readmission. Reasons for readmission were divided into access related, dialysis catheter related, and other causes, which included shortness of breath/volume overload, gastrointestinal causes, chest pain, unrelated infectious causes, failure to thrive, altered mental status, electrolyte abnormalities, and musculoskeletal causes. Emergency department visits #90 days not requiring admission were also recorded.
Patient and procedural factors (fistula type and patient demographics and comorbidities) are described with counts and percentages. Counts and percentages of readmission were reported for each factor level. Logistic regression models were used to evaluate the association of each individual factor with 30-day or 90-day readmission. All factors were then entered into multivariable logistic regressions for each outcome. A backward elimination procedure with 0.5 and 0.2 level to keep in the model was used to construct parsimonious models.
The associations of patient characteristics and readmission are expressed by adjusted odds ratios (ORs) with the corresponding 95% confidence intervals (CIs). Statistical analyses were performed using SAS 9.3 software (SAS Institute Inc, Cary, NC). For all tests, a P < .05 was considered statistically significant. Tables I and II report the demographics, comorbidities, and procedure-specific details associated with 30-day and 90-day readmissions. Table III reports details for 90-day access-related readmissions.
RESULTS

Between
Reasons for the index readmission #90 days were related to the access in 10.9% and to the dialysis catheter in 6.9%. Vascular access-related readmissions reasons were infection (50%), arm swelling (18.2%), bleeding (13.6%), thrombosis (13.6%), and steal (4.5%). Catheterrelated readmissions were for infection (57%) and malfunction (43%). Other reasons for readmission included shortness of breath/volume overload (15.8%), gastrointestinal causes (11.9%), cardiac/chest pain (10.9%), unrelated infectious causes (11.9%), failure to thrive (5%), altered mental status (4%), electrolyte abnormalities (3%), and musculoskeletal causes (2.5%). An additional 9.7% of patients had at least one emergency department presentation #90 days but were not admitted.
Multivariate logistic regression analysis of 30-day readmission revealed that patients who had dementia (OR, 5.77; 95% CI, 1.34-24.78; P ¼ .018), hypertension (OR, 3.93; 95% CI, 1.07-14.42; P ¼ .039), or COPD (OR, 2.19; 95% CI, 1.01-4.76; P ¼ .046), or were current smokers (OR, 2.14; 95% CI, 1.32-3.47; P ¼ .002) were at a higher odds of all-cause readmission (Table IV) (Table VI) . Placement of a brachiobasilic or other fistula, patient age, impaired ambulatory status, obesity, smoking status, and comorbidities, such as diabetes, CHF, and PVD, did not increase access-related 90-day readmission.
DISCUSSION
Readmission rates after outpatient upper extremity hemodialysis access were high, with almost half of patients being readmitted #90 days. Only a minority of readmissions were related to the access placement. Most readmissions were a result of unrelated medical problems, and the patients were admitted to a medical service. Many patients had multiple readmissions #90 days. Risk factors for 30-day readmission were dementia, hypertension, COPD, and current smoking. Risk factors for 90-day readmission included liver failure, hypertension, black race, Hispanic ethnicity, and obesity. Access-related readmissions were associated with COPD, previous prosthetic graft placement, dialysis at the time of the operation, and female gender. Surprisingly, being on dialysis at the time of the operation was not an independent risk factor. Hospitals and surgeons are under pressure to reduce postoperative readmissions. Vascular surgery practices have one of the highest readmission rates and are potentially a target for future financial penalties. Previous studies with lower extremity bypass and critical limb ischemia have shown that such patients are at high risk for readmission. In contrast to lower extremity bypass, arterial-venous fistulas and grafts have small incisions, are often performed as an ambulatory procedure, and have a low periprocedural complication rate. Failure of a newly created access should not necessarily result in a readmission or reoperation as would potentially be the case for leg bypass. Despite the relatively low invasiveness of these operations, particularly among outpatients, readmission rates, driven by medical comorbidities, are high.
Our readmission rates of 25.5% at 30 days and 47.7% at 90 days are higher than the reported overall hospital readmission rates of 17% at 30 days and 27% at 90 days for inpatients in the Medicare database. 12 This is not surprising, given that end-stage renal disease has been shown to be a strong risk factor for readmission and postoperative complications after vascular and nonvascular operations. 5, 7, [14] [15] [16] [17] Traditionally, inpatient procedures that have begun to be performed as ambulatory operations, such as laparoscopic cholecystectomy, thyroidectomy, and sleeve gastrectomy, have relatively low readmission rates of between 0.9% and 8.5%. [18] [19] [20] [21] In contrast, readmission rates of our outpatient vascular access operations are very high. We identified risk factors that were associated with readmission. Many of these are chronic conditions such as dementia, hypertension, COPD, liver failure, and obesity. As such, one potential way to limit readmissions would be to improve the communication between access surgeons and primary care providers and nephrologists to arrange and optimize close outpatient postoperative follow-up. Another option would be to place access on high-risk patients as inpatients rather than as outpatients. Although we can only speculate that these measures would help, this would require a future prospective analysis.
The presence of race as a risk factor of 90-day readmissions reaffirms that certain racial groups are at higher risk. Prosthetic graft use was associated with procedure-related readmission. This is not surprising, because these patients have most likely exhausted their upper extremity autogenous veins, and grafts are associated with higher rates of failure and infectious and noninfectious complications. [22] [23] [24] By identifying high-risk patients, better communication with primary care physicians and nephrologists for these patients may potentially allow for better medical optimization perioperatively. Alternatively, the rate of readmission may not be able to be improved much in this high-risk group, and administrators and payers can use these data for proper resource allocation. This study has certain limitations. This was a retrospective record review and contains all the inherent limitations of a retrospective cohort study. The data were collected from a single institution and may represent different patterns than the vascular surgery population at large. The cause for readmission is based on case review, and there may be more than one confounding factor, although the main reason was recorded.
CONCLUSIONS
Patients undergoing placement of hemodialysis access are at high risk for readmission mostly from causes unrelated to their operation. Enhanced outpatient medical optimization of these patients may lead to a decrease in readmissions postoperatively. This has an effect for the global care for these patients as well as the care of these patients in accountable care organizations. Future analysis is needed to prospectively see what can be done to improve readmission rates and to assess the financial strain on systems. 
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